These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21956791)

  • 1. Understanding and assessing adverse drug reactions.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2011 Oct; 49(10):13-5. PubMed ID: 21956791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.
    Koh Y; Yap CW; Li SC
    Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions among inpatients in a north Indian referral hospital.
    Uppal R; Jhaj R; Malhotra S
    Natl Med J India; 2000; 13(1):16-8. PubMed ID: 10743370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A questionnaire for the clinical assessment of veterinary adverse drug reactions.
    Hoskins JD; Hubbert WT; Selig JO
    Cornell Vet; 1982 Jan; 72(1):3-15. PubMed ID: 7067454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients.
    Seeger JD; Kong SX; Schumock GT
    Pharmacotherapy; 1998; 18(6):1284-9. PubMed ID: 9855328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug related hospital admissions in subspecialities of internal medicine.
    Hallas J
    Dan Med Bull; 1996 Apr; 43(2):141-55. PubMed ID: 8741207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection and evaluation of adverse drug effects].
    Thürmann PA; Schmitt K
    Med Klin (Munich); 2000 May; 95(1 Spec No):4-8. PubMed ID: 10851841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three algorithms used to evaluate adverse drug reactions.
    Michel DJ; Knodel LC
    Am J Hosp Pharm; 1986 Jul; 43(7):1709-14. PubMed ID: 3752106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions in a south Indian hospital--their severity and cost involved.
    Ramesh M; Pandit J; Parthasarathi G
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):687-92. PubMed ID: 14762985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary program for detecting and evaluating adverse drug reactions.
    Keith MR; Bellanger-McCleery RA; Fuchs JE
    Am J Hosp Pharm; 1989 Sep; 46(9):1809-12. PubMed ID: 2801715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Principle of adverse drug reaction causality judgement and interpretation of causality assessment method both in China and abroad].
    Wei X; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2744-7. PubMed ID: 23285925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of adverse drug reactions in a dermatology department.
    Ganeva M; Gancheva T; Lazarova R; Tzvetanova Y; Hristakieva E
    Methods Find Exp Clin Pharmacol; 2007 Mar; 29(2):107-12. PubMed ID: 17440627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic risk-assessment model for identifying patients with adverse drug reactions.
    Tschepik W; Segal R; Sherrin TP; Schneider DN; Hammond RL
    Am J Hosp Pharm; 1990 Feb; 47(2):330-4. PubMed ID: 2309721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New ways to detect adverse drug reactions in pediatrics.
    Rieder M
    Pediatr Clin North Am; 2012 Oct; 59(5):1071-92. PubMed ID: 23036245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit?
    Kane-Gill SL; Kirisci L; Pathak DS
    Ann Pharmacother; 2005 Nov; 39(11):1823-7. PubMed ID: 16204392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Under-reporting of serious adverse drug reactions in Sweden.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center.
    Mey C; Hentschel H; Hippius M; Balogh A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):102-7. PubMed ID: 11911597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of three methods of detecting adverse drug reactions.
    Berry LL; Segal R; Sherrin TP; Fudge KA
    Am J Hosp Pharm; 1988 Jul; 45(7):1534-9. PubMed ID: 3046347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions: a review of relevant factors.
    Ajayi FO; Sun H; Perry J
    J Clin Pharmacol; 2000 Oct; 40(10):1093-101. PubMed ID: 11028248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.